A new era of testosterone and prostate cancer: from physiology to clinical implications.
about
The dark side of 5α-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depressionEffects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studiesTestosterone treatment is a potent tumor promoter for the rat prostate.Testosterone and weight loss: the evidence.Current state of practice regarding testosterone supplementation therapy in men with prostate cancerTestosterone deficiency and cardiovascular mortality.Androgens and esophageal cancer: What do we know?Diagnosis and management of testosterone deficiencyControversies in testosterone supplementation therapy.Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer.Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomyAssociation between Metformin Use and Cancer Stage at Diagnosis among Elderly Medicare Beneficiaries with Preexisting Type 2 Diabetes Mellitus and Incident Prostate Cancer.Testosterone therapy and prostate cancer.The association between sexual function and prostate cancer risk in US veterans.The safety of testosterone supplementation therapy in prostate cancer.Testosterone and cardiovascular disease--the controversy and the facts.Low Testosterone Alters the Activity of Mouse Prostate Stem Cells.Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results.The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis.Testosterone Therapy in Men With Prostate Cancer.Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.The Association of Diabetes and Obesity With Prostate Cancer Progression: HCaP-NC.The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study.Use of statins offsets insulin-related cancer risk.Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer.Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger menSerum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy resultEffects of Testosterone Level on Lower Urinary Tract Symptoms.Low testosterone level is an independent risk factor for high-grade prostate cancer detection at biopsy.Diagnosing hypogonadism and treating decisions in different parts of the world: shifts in patterns between 2006 and 2015.The role of the serum testosterone levels as a predictor of prostate cancer in patients with atypical small acinar proliferation at the first prostate biopsy.Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.Testosterone deficiency syndrome and cardiovascular health: Looking carefully at the evidence.The emancipation of testosterone from niche hormone to multi-system player.A critical analysis of the 2014 CUA guidelines for erectile dysfunction: Is there more that can be done?Re: The treatment of late-onset hypogonadism.Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.
P2860
Q24564068-A11ABBE4-1779-4D37-8075-05E548529B9AQ30983590-2C17C926-9D2F-4F6E-A159-0BCB5870E83BQ33569704-0603D903-6C94-4D06-AEE6-99F50C1DFE88Q34134273-69C064E5-A910-40D4-8E55-FBBB715C2FE6Q34293663-54E49B01-1993-44B3-84C1-A9B2ECF563C5Q34927884-BF30840D-BADD-47A0-9EAE-92FB6DA61C36Q35651459-E610E618-43F5-4CFC-BE98-A92124007422Q36293061-A0D078BF-477F-4FE2-B919-1642B6FC5326Q36293076-EEFA4B2A-AF90-4160-845A-BA945271DC3DQ36293127-712393E9-2068-45BE-B24A-3EB128F4AFDAQ36319340-09A86044-3C64-4698-B480-40ACC9C8D205Q36530243-8CB5B029-FB2C-469D-AD92-92B0F523BA46Q37172118-D01DFC63-1C03-4646-BE47-16CF2170386AQ37531045-EC96710B-DC2F-437F-AF99-510ED112EAD7Q37644663-F355062D-54EF-435B-BA72-BD1E5BECFE02Q38234728-B4609C37-FA67-4D8E-93AC-0EEA8811DE47Q38364486-90C43DEA-D9F8-421C-9081-6173499596C4Q38439120-AB50754B-96D5-4FC4-9E06-2D730828A460Q38532217-56EFE32D-E8B9-461C-B8F8-0F3F870167EEQ38573757-6CA5B5C2-F46B-4905-968F-D0331B214CE9Q38675578-48B50023-6FCE-42C7-8255-B60A3383A387Q38683604-0A5DAD44-33E1-45E1-8DC9-FC51209FA9A6Q38739186-CA3AF31C-D9D6-41C2-9F63-C777A2A0C615Q38928135-A5962C86-96FF-4C52-8D53-0B28F49CE14FQ39199949-324550CB-80C7-43D1-A5AC-4A67381861AEQ39263827-BD16BC18-E5CA-4DAA-B28F-13A3437C97A3Q39354036-EC147692-3AC6-437B-BD0F-4242B60ABB07Q39467373-7525C78F-342D-4EA4-AAFD-1F6F52186703Q39483117-387ABF67-B38E-4025-826A-07A495B6E133Q40288734-BBB87E2A-D0F0-451A-BE21-22CCAACB432AQ40289446-9EE1623C-0653-448B-8D1A-1CA6B9685594Q40342016-05394F17-6189-4A0B-B6C5-305B1C7C3235Q40485378-CF0353F4-CFAD-4ADA-A68C-1D6B3355F1E3Q40582717-D6F25ECD-8183-4A20-87BD-ECFEA04DC6B0Q41089585-BBDCCA7F-7834-4BF1-8B72-9AD47B1F4BCDQ41966564-54EAE6E4-822B-4D1F-8902-51DF413CBED5Q41999758-B57A6EC4-98F3-4E95-9C2D-06C034F7E734Q42139168-174DFA6B-AE98-40D6-8582-3F9F5ABC6DA6Q42258789-945D3AF4-CC80-4A04-A310-7B2F5DCFD0FFQ45351575-FCE2A205-D9E3-4B1A-90E0-A69E1252BDD9
P2860
A new era of testosterone and prostate cancer: from physiology to clinical implications.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A new era of testosterone and prostate cancer: from physiology to clinical implications.
@en
type
label
A new era of testosterone and prostate cancer: from physiology to clinical implications.
@en
prefLabel
A new era of testosterone and prostate cancer: from physiology to clinical implications.
@en
P2093
P1433
P1476
A new era of testosterone and prostate cancer: from physiology to clinical implications.
@en
P2093
Abraham Morgentaler
Alvaro Morales
Andrea Salonia
David Crawford
Mohit Khera
P304
P356
10.1016/J.EURURO.2013.08.015
P407
P577
2013-08-16T00:00:00Z